For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Remifentanil (Opioid analgesic (µ-agonist, ultra-short-acting, metabolised by non-specific esterases)) – indications: Induction of anaesthesia (adults, only together with a hypnotic), Maintenance of anaesthesia (ventilated), Anaesthesia/sedation and analgesia with spontaneous breathing, Analgesia in ventilated ICU patients (adults from 18 y). Weight-based dosing in mg and ml in the app, with sources.
Indications
- Induction of anaesthesia (adults, only together with a hypnotic)
- Maintenance of anaesthesia (ventilated)
- Anaesthesia/sedation and analgesia with spontaneous breathing
- Analgesia in ventilated ICU patients (adults from 18 y)
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.